ELSAN Group, Polyclinique Les Fleurs, 332 avenue Frédéric Mistral, Ollioules, 83190, France.
ELSAN Group, Clinique Rhône Durance, 1750 chemin du Lavarin, Avignon, 84000, France.
Trials. 2023 Aug 29;24(1):560. doi: 10.1186/s13063-023-07458-y.
Treatment of chronic total occlusion (CTO) by percutaneous coronary intervention (PCI) is associated with the difficulty of guidewire manipulation through the occluded segment, particularly when there is hard tissue due to calcification. The purpose of this randomised controlled trial is to determine whether improved planning of CTO-PCI using coronary computed tomographic angiography (CCTA) (versus conventional angiography) increases success rates of wire crossing in ≤ 60 min in difficult cases.
This is a randomised controlled open-label multi-centre trial in a superiority framework with 1:1 allocation ratio. Participants (n = 130) will be randomised into two groups: the study group who will receive standard of care with the addition of preoperative coronary computed tomographic angiography (CT group), and the control group that will receive standard of care (angiography group). The primary endpoint will be the rate of successful wire crossing in ≤ 60 min in complex CTO (J-CTO ≥ 2). Wire crossing will be considered successful if TIMI flow 3 is restored and residual stenosis is < 30%. The safety endpoint will be mortality due to the intervention or major adverse cardiac events (MACE). Secondary endpoints are success rates at any time; total time of PCI; time of wire crossing; rate of PCI complications; radiation levels during PCI; volume of iodine contrast medium administered; and cost of the PCI.
This randomised trial will provide insight into whether pre-procedural CCTA as opposed to conventional angiography for planning of CTO-PCI yield higher success rates of wire crossing in ≤ 60 min. Potential benefits of CCTA include shorter successful procedure times of CTO-PCI leading to less irradiation and contrast medium with lower complication rates.
Clinical Trials.gov NCT04549896. Registered on December 21, 2021.
经皮冠状动脉介入治疗(PCI)治疗慢性完全闭塞(CTO)与导丝在闭塞段的操作难度有关,尤其是当存在由于钙化导致的硬组织时。本随机对照试验的目的是确定使用冠状动脉计算机断层扫描血管造影(CCTA)(与常规血管造影相比)对 CTO-PCI 进行改良规划是否能提高≤60 分钟内导丝交叉的成功率,特别是在困难病例中。
这是一项在优效性框架内进行的、以 1:1 比例分配的随机对照、开放标签、多中心试验。将参与者(n=130)随机分为两组:接受标准治疗并加用术前冠状动脉计算机断层扫描血管造影(CT 组)的研究组和接受标准治疗(血管造影组)的对照组。主要终点是复杂 CTO(J-CTO≥2)中≤60 分钟内成功导丝交叉的比率。如果 TIMI 血流 3 恢复且残余狭窄<30%,则认为导丝交叉成功。安全性终点是由于干预或主要不良心脏事件(MACE)导致的死亡率。次要终点是任何时间的成功率;PCI 的总时间;导丝交叉时间;PCI 并发症发生率;PCI 期间的辐射水平;给予的碘造影剂体积;以及 PCI 的成本。
这项随机试验将提供关于在 CTO-PCI 规划中,与常规血管造影相比,术前 CCTA 是否能提高≤60 分钟内导丝交叉的成功率的信息。CCTA 的潜在益处包括缩短 CTO-PCI 的成功手术时间,从而减少辐射和造影剂,降低并发症发生率。
ClinicalTrials.gov NCT04549896。于 2021 年 12 月 21 日注册。